المؤلفون: Blazek O; Department of Medicine, Am Heart Assoc. Comprehensive Hypertension Center, The University of Chicago Medicine, Chicago, IL, USA. Electronic address: oblazek@iu.edu., Bakris GL; Department of Medicine, Am Heart Assoc. Comprehensive Hypertension Center, The University of Chicago Medicine, Chicago, IL, USA. Electronic address: gbakris@uchicago.edu.

المصدر: European journal of pharmacology [Eur J Pharmacol] 2024 Sep 15; Vol. 979, pp. 176752. Date of Electronic Publication: 2024 Jul 22.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: Elsevier Science Country of Publication: Netherlands NLM ID: 1254354 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0712 (Electronic) Linking ISSN: 00142999 NLM ISO Abbreviation: Eur J Pharmacol Subsets: MEDLINE

مواضيع طبية MeSH: Mineralocorticoid Receptor Antagonists*/therapeutic use , Mineralocorticoid Receptor Antagonists*/pharmacology , Hypertension*/drug therapy , Hypertension*/physiopathology , Endothelin Receptor Antagonists*/therapeutic use , Endothelin Receptor Antagonists*/pharmacology, Humans ; Animals ; Antihypertensive Agents/therapeutic use ; Antihypertensive Agents/pharmacology ; Blood Pressure/drug effects ; Drug Resistance

المؤلفون: Tamargo J; Department of Pharmacology and Toxicology, School of Medicine, Universidad Complutense, Plaza de Ramón y Cajal s/n, 28040 Madrid, Spain.

المصدر: European heart journal. Cardiovascular pharmacotherapy [Eur Heart J Cardiovasc Pharmacother] 2024 Aug 14; Vol. 10 (5), pp. 371-373.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Oxford University Press Country of Publication: England NLM ID: 101669491 Publication Model: Print Cited Medium: Internet ISSN: 2055-6845 (Electronic) NLM ISO Abbreviation: Eur Heart J Cardiovasc Pharmacother Subsets: MEDLINE

مواضيع طبية MeSH: Endothelin Receptor Antagonists*/therapeutic use , Endothelin Receptor Antagonists*/adverse effects , Hypertension*/drug therapy , Hypertension*/physiopathology , Drug Approval*, Humans ; Sulfonamides/therapeutic use ; Antihypertensive Agents/therapeutic use ; Antihypertensive Agents/adverse effects ; Pyrimidines/therapeutic use ; Pyrimidines/adverse effects

المؤلفون: Hunter-Dickson M; Department of Renal Medicine, Concord Repatriation General Hospital, Concord, New South Wales, Australia., Wong MG; Department of Renal Medicine, Concord Repatriation General Hospital, Concord, New South Wales, Australia.; Concord Clinical School, University of Sydney, Concord, New South Wales, Australia.

المصدر: Nephrology (Carlton, Vic.) [Nephrology (Carlton)] 2024 Sep; Vol. 29 Suppl 2, pp. 30-33.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: Blackwell Science Country of Publication: Australia NLM ID: 9615568 Publication Model: Print Cited Medium: Internet ISSN: 1440-1797 (Electronic) Linking ISSN: 13205358 NLM ISO Abbreviation: Nephrology (Carlton) Subsets: MEDLINE

مواضيع طبية MeSH: Glomerulonephritis, IGA*/drug therapy , Endothelin Receptor Antagonists*/therapeutic use, Humans ; Treatment Outcome ; Proteinuria/drug therapy

المؤلفون: Ram CVS; Apollo Group of Hospitals, Hyderabad, India; University of Texas Southwestern Medical Center, Dallas. Electronic address: drram_v@apollohospitals.com.

المصدر: The American journal of medicine [Am J Med] 2024 Sep; Vol. 137 (9), pp. 795-798. Date of Electronic Publication: 2024 May 13.

نوع المنشور: Editorial

بيانات الدورية: Publisher: Excerpta Medica Country of Publication: United States NLM ID: 0267200 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1555-7162 (Electronic) Linking ISSN: 00029343 NLM ISO Abbreviation: Am J Med Subsets: MEDLINE

مواضيع طبية MeSH: Hypertension*/drug therapy , Antihypertensive Agents*/therapeutic use , Drug Approval* , Endothelin Receptor Antagonists*/therapeutic use, Humans ; United States ; United States Food and Drug Administration

المؤلفون: Bearzi P; Rheumatology, Immunology and Clinical Medicine Unit, Department of Medicine, Università Campus Bio-Medico, Roma, Italy., Navarini L; Rheumatology, Immunology and Clinical Medicine Unit, Department of Medicine, Università Campus Bio-Medico, Rome, and Immunorheumatology Unit, Fondazione Policlinico Universitario Campus Bio Medico, Rome, Italy., Currado D; Rheumatology, Immunology and Clinical Medicine Unit, Department of Medicine, Università Campus Bio-Medico, Rome, and Immunorheumatology Unit, Fondazione Policlinico Universitario Campus Bio Medico, Rome, Italy., Marino A; Immunorheumatology Unit, Fondazione Policlinico Universitario Campus Bio Medico, Rome, Italy., Minerba M; Rheumatology, Immunology and Clinical Medicine Unit, Department of Medicine, Università Campus Bio-Medico, Roma, Italy., Salvolini C; Rheumatology, Immunology and Clinical Medicine Unit, Department of Medicine, Università Campus Bio-Medico, Roma, Italy., Perrone A; Rheumatology, Immunology and Clinical Medicine Unit, Department of Medicine, Università Campus Bio-Medico, Roma, Italy., Frascà L; Rheumatology, Immunology and Clinical Medicine Unit, Department of Medicine, Università Campus Bio-Medico, Roma, Italy., Liakouli V; Rheumatology Research Unit, Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy., Vomero M; Rheumatology, Immunology and Clinical Medicine Unit, Department of Medicine, Università Campus Bio-Medico, Roma, Italy., Berardicurti O; Rheumatology, Immunology and Clinical Medicine Unit, Department of Medicine, Università Campus Bio-Medico, Rome, and Immunorheumatology Unit, Fondazione Policlinico Universitario Campus Bio Medico, Rome, Italy. o.berardicurti@policlinicocampus.it., Giacomelli R; Rheumatology, Immunology and Clinical Medicine Unit, Department of Medicine, Università Campus Bio-Medico, Rome, and Immunorheumatology Unit, Fondazione Policlinico Universitario Campus Bio Medico, Rome, Italy.

المصدر: Clinical and experimental rheumatology [Clin Exp Rheumatol] 2024 Aug; Vol. 42 (8), pp. 1615-1622. Date of Electronic Publication: 2024 May 28.

نوع المنشور: Systematic Review; Journal Article; Meta-Analysis

بيانات الدورية: Publisher: Clinical And Experimental Rheumatology S.A.S Country of Publication: Italy NLM ID: 8308521 Publication Model: Print-Electronic Cited Medium: Print ISSN: 0392-856X (Print) Linking ISSN: 0392856X NLM ISO Abbreviation: Clin Exp Rheumatol Subsets: MEDLINE

مواضيع طبية MeSH: Bosentan*/therapeutic use , Scleroderma, Systemic*/complications , Scleroderma, Systemic*/drug therapy , Scleroderma, Systemic*/physiopathology , Hypertension, Pulmonary*/drug therapy , Hypertension, Pulmonary*/etiology , Hypertension, Pulmonary*/physiopathology , Hypertension, Pulmonary*/diagnostic imaging , Antihypertensive Agents*/therapeutic use , Endothelin Receptor Antagonists*/therapeutic use , Arterial Pressure*/drug effects , Pulmonary Artery*/drug effects , Pulmonary Artery*/physiopathology , Pulmonary Artery*/diagnostic imaging, Humans ; Echocardiography ; Treatment Outcome ; Pulmonary Arterial Hypertension/drug therapy ; Pulmonary Arterial Hypertension/physiopathology ; Pulmonary Arterial Hypertension/etiology ; Pulmonary Arterial Hypertension/diagnostic imaging

المؤلفون: Stasinopoulou M; Center of Clinical, Experimental Surgery, and Translational Research, Biomedical Research Foundation, Academy of Athens, 115 27 Athens, Greece., Kostomitsopoulos N; Center of Clinical, Experimental Surgery, and Translational Research, Biomedical Research Foundation, Academy of Athens, 115 27 Athens, Greece., Kadoglou NPE; Medical School, University of Cyprus, 2029 Nicosia, Cyprus.

المصدر: International journal of molecular sciences [Int J Mol Sci] 2024 Jun 16; Vol. 25 (12). Date of Electronic Publication: 2024 Jun 16.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium: Internet ISSN: 1422-0067 (Electronic) Linking ISSN: 14220067 NLM ISO Abbreviation: Int J Mol Sci Subsets: MEDLINE

مواضيع طبية MeSH: Bosentan*/pharmacology , Bosentan*/therapeutic use , Atorvastatin*/pharmacology , Atorvastatin*/therapeutic use , Atherosclerosis*/drug therapy , Atherosclerosis*/metabolism , Atherosclerosis*/pathology , Endothelin Receptor Antagonists*/pharmacology , Endothelin Receptor Antagonists*/therapeutic use, Animals ; Mice ; Male ; Diabetes Mellitus, Experimental/drug therapy ; Drug Therapy, Combination ; Collagen/metabolism ; Diet, High-Fat/adverse effects ; Chemokine CCL2/metabolism ; Chemokine CCL2/genetics ; Tumor Necrosis Factor-alpha/metabolism ; Plaque, Atherosclerotic/drug therapy ; Plaque, Atherosclerotic/pathology ; Plaque, Atherosclerotic/metabolism ; Mice, Knockout ; Tissue Inhibitor of Metalloproteinase-1/metabolism

المؤلفون: Cantor J; School of Pharmacy and Health Sciences, Queens, NY 11439, USA.

المصدر: International journal of molecular sciences [Int J Mol Sci] 2024 Apr 10; Vol. 25 (8). Date of Electronic Publication: 2024 Apr 10.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium: Internet ISSN: 1422-0067 (Electronic) Linking ISSN: 14220067 NLM ISO Abbreviation: Int J Mol Sci Subsets: MEDLINE

مواضيع طبية MeSH: Pulmonary Fibrosis*/drug therapy , Pulmonary Fibrosis*/metabolism , Pulmonary Fibrosis*/pathology , Endothelin Receptor Antagonists*/pharmacology , Endothelin Receptor Antagonists*/therapeutic use, Animals ; Bleomycin/adverse effects ; Cricetinae ; Disease Models, Animal ; Male ; Lung/pathology ; Lung/drug effects ; Lung/metabolism ; Humans ; Endothelin-1/metabolism

المؤلفون: Brussee JM; Department of Clinical Pharmacology, Idorsia Pharmaceuticals Ltd, Hegenheimermattweg 91, Allschwil, 4123, Switzerland., Sidharta PN; Department of Clinical Pharmacology, Idorsia Pharmaceuticals Ltd, Hegenheimermattweg 91, Allschwil, 4123, Switzerland., Dingemanse J; Department of Clinical Pharmacology, Idorsia Pharmaceuticals Ltd, Hegenheimermattweg 91, Allschwil, 4123, Switzerland., Krause A; Department of Clinical Pharmacology, Idorsia Pharmaceuticals Ltd, Hegenheimermattweg 91, Allschwil, 4123, Switzerland. ak@elmo.ch.

المصدر: Journal of pharmacokinetics and pharmacodynamics [J Pharmacokinet Pharmacodyn] 2024 Jun; Vol. 51 (3), pp. 243-252. Date of Electronic Publication: 2024 Feb 08.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Springer Country of Publication: United States NLM ID: 101096520 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-8744 (Electronic) Linking ISSN: 1567567X NLM ISO Abbreviation: J Pharmacokinet Pharmacodyn Subsets: MEDLINE

مواضيع طبية MeSH: Endothelin Receptor Antagonists*/pharmacokinetics , Endothelin Receptor Antagonists*/administration & dosage , Hypertension*/drug therapy , Models, Biological*, Adult ; Aged ; Aged, 80 and over ; Female ; Humans ; Male ; Middle Aged ; Young Adult ; Antihypertensive Agents/pharmacokinetics ; Antihypertensive Agents/administration & dosage ; Antihypertensive Agents/therapeutic use ; Dose-Response Relationship, Drug ; Glomerular Filtration Rate/drug effects ; Pyrimidines/pharmacokinetics ; Pyrimidines/administration & dosage ; Pyrimidines/therapeutic use ; Sulfonamides

المؤلفون: Schinzari F; Department of Aging, Policlinico A. Gemelli IRCCS, Roma, Italy., Tesauro M; Department of Systems Medicine, Università Tor Vergata, Roma, Italy., Cardillo C; Department of Translational Medicine and Surgery, Università Cattolica del Sacro Cuore, Roma, Italy.

المصدر: Clinical science (London, England : 1979) [Clin Sci (Lond)] 2024 Jun 05; Vol. 138 (11), pp. 635-644.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: Portland Press on behalf of the Medical Research Society and the Biochemical Society Country of Publication: England NLM ID: 7905731 Publication Model: Print Cited Medium: Internet ISSN: 1470-8736 (Electronic) Linking ISSN: 01435221 NLM ISO Abbreviation: Clin Sci (Lond) Subsets: MEDLINE

مواضيع طبية MeSH: Endothelin Receptor Antagonists*/therapeutic use , Endothelins*/metabolism, Humans ; Animals ; Receptors, Endothelin/metabolism

المؤلفون: Abraham GR; Division of Experimental Medicine and Immunotherapeutics, University of Cambridge, Addenbrooke's Hospital, Cambridge, UK.; Royal Papworth Hospital NHS Foundation Trust, Cambridge Biomedical Campus, Cambridge, UK., Williams TL; Division of Experimental Medicine and Immunotherapeutics, University of Cambridge, Addenbrooke's Hospital, Cambridge, UK., Maguire JJ; Division of Experimental Medicine and Immunotherapeutics, University of Cambridge, Addenbrooke's Hospital, Cambridge, UK., Greasley PJ; Early Clinical Development, Research and Early Development, Cardiovascular, Renal and Metabolism (CVRM), BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden., Ambery P; Late-Stage Development, Cardiovascular, Renal and Metabolism (CVRM), BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden., Davenport AP; Division of Experimental Medicine and Immunotherapeutics, University of Cambridge, Addenbrooke's Hospital, Cambridge, UK. apd10@medschl.cam.ac.uk.

المصدر: Nature cardiovascular research [Nat Cardiovasc Res] 2023 Nov; Vol. 2 (11), pp. 972-990. Date of Electronic Publication: 2023 Nov 02.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: Springer Nature Country of Publication: England NLM ID: 9918284280206676 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2731-0590 (Electronic) Linking ISSN: 27310590 NLM ISO Abbreviation: Nat Cardiovasc Res Subsets: MEDLINE

مواضيع طبية MeSH: Cardiovascular Diseases*/drug therapy , Cardiovascular Diseases*/metabolism , Endothelin Receptor Antagonists*/therapeutic use , Endothelin Receptor Antagonists*/pharmacology, Humans ; COVID-19 ; Animals ; Signal Transduction/drug effects ; Endothelin-1/metabolism ; Endothelin-1/antagonists & inhibitors ; SARS-CoV-2/drug effects ; Endothelins/metabolism